Hogan Lovells has advised HLS Therapeutics Inc. on the deal. HLS Therapeutics Inc. (TSX: HLS) sold its royalty interest and milestone payment obligations in the global...
DRI Healthcare Trust’s Acquisition Of XENPOZYME From HLS Therapeutics Inc.
TDCX Inc.’s $1.037 Billion Going Private Transaction
On the transaction, Hogan Lovells acted as U.S. legal counsel to the Special Committee of the Board of Directors of TDCX Inc.; Skadden, Arps, Slate, Meagher...